Person: BEKTAY, MUHAMMED YUNUS
Loading...
Status
Kurumdan Ayrılmıştır.
Organizational Units
16 results
Search Results
Now showing 1 - 10 of 16
Publication Metadata only Determination of Pharmaceutical Care Needs of COVID-19 Patients in the 1st Wave of Pandemic(2021-09-08T00:00:00Z) Gökçe, Naçize; Bektay, Muhammed Yunus; İzzettin, Fikret Vehbi; BEKTAY, MUHAMMED YUNUS; İZZETTİN, FIKRET VEHBITurkey In 2020 COVID-19 pandemic spread all over the world. A multidisciplinary approach isnecessary for the treatment. The aim of this study is to determine the pharmaceutical care need of COVID-19 patients in the 1st wave of the pandemic. A retrospective, observational study was conducted. After ethical approval was given with 13/274 number, prescription records were investigated by a clinical pharmacist (CP). drug-related problems (DRP)identified through prescription examination. Study was held in 2 branches (i) hospitalized patients (HP) where CP is present and (ii) ambulatory care patients (AP). In this study 183HP and 182 AP patients prescriptions were examined. Half of the participants were female89 (%48.6), 83 (%45.6) for HP and AP respectively. The mean±SD age for HPs and APs were42±18, 42,5±16 respectively. Many participants had multiple comorbidities, in HPs 91(%49.5) at least have 2 or more existing diseases. The median medication number of HPsand APs were 7, 5 respectively. CP identified DRP events for HPs and APs 144, 306respectively. The most common DRP for HPs was using ondansetron instead of metoclopramide. On the other hand, the most prevalent DRP for APs was lack of any gastroprotective medication. DRPs are probable events. Our results demonstrated that HPshad a lower number of DRPs. This points out that CP is a valuable asset to prevent DRPs. In conclusion, every setting where a clinical pharmacist is present should be involved in the healthcare and take responsibility.Publication Metadata only Are Students Using Pharmacological Cognitive Enhancement More Successful?(2021-09-08T00:00:00Z) Sümbül Şekerci, Betül; Bektay, Muhammed Yunus; Bildik, Özlem; İzzettin, Fikret Vehbi; SÜMBÜL ŞEKERCİ, BETÜL; BEKTAY, MUHAMMED YUNUS; BİLDİK, ÖZLEM; İZZETTİN, FIKRET VEHBIIntroduction: The use of psychostimulant drugs to increase academic success is common among young people, especially medical students. However, the effect of psychostimulants on academic success not clear in the current literature. Materials and Methods: A structured online survey was carried out with 431 undergraduate students in different faculties of Medicine in Turkey. Comparisons between groups, correlation and regression analysis about associated variables were made. The academic performance of the students was evaluated with grade point average (GPA) score. Also, academic success, academic anxiety, study performance, sleep quality and pharmacological knowledge levels were questioned with the scale based on self-evaluations. Results: 23 (5.4%) healthy students reported using psychostimulants to improve academic success. There was no significant difference in age, gender, semester, objective (GPA score) and subjective (self-report) assessment of success between users and non-users. But most of the users evaluated that the psychostimulants are useful. Smoking and increased knowledge level of pharmacology are risk factors for psychostimulant use. Conclusion: We could not find a relationship between academic success and pharmacological cognitive enhancement. Psychostimulant use had an positive effect on self-assessment of students. It can support the hypothesis that the psychostimulants has a motivational contribution rather than a purely pharmacological effect. The relationship of psychostimulants with alcohol and smoking should be examined in detail, and users should be questioned in terms of susceptibility to risky behaviors and addiction.Publication Metadata only Investigation of the Anxiety and Knowledge Levels of Individuals: the Role of Pharmacist(2021-09-08T00:00:00Z) Tütüncü, Beyza; Sosyal, Damla; Bektay, Muhammed Yunus; İzzettin, Fikret Vehbi; SOSYAL, DAMLA; BEKTAY, MUHAMMED YUNUS; İZZETTİN, FIKRET VEHBIPublication Open Access Insight into Turkish Community Pharmacists’ Services in the First Wave of the COVID-19 Pandemic(2021-06-01T00:00:00Z) Okuyan, Betül; İzzettin, Fikret Vehbi; BEKTAY, MUHAMMED YUNUS; İZZETTİN, FIKRET VEHBIPublication Open Access Time to change to improve health: clinical pharmacy and pharmaceutical care education in Turkey(2020-05-01T00:00:00Z) Bektay, Muhammed Yunus; Sancar, Mesut; Al-Ezzı, Saad Ahmed Ali; BEKTAY, MUHAMMED YUNUS; AL-EZZI, SAAD AHMED ALİ; İZZETTİN, FIKRET VEHBIThe practice of clinical pharmacy had a positive impact on the profession by giving pharmacists more job opportunities. Moreover, the pharmacy began to gain the status it deserved, which was lost many years ago. In this paper, we aimed to give a brief explanation of the clinical pharmacy philosophy and definition of pharmaceutical care. What are the general and specific roles of clinical pharmacists in the modern world healthcare system? Also, how to implement clinical pharmacy in education to obtain competent pharmacists. We shared our observation and experience, specifically on the progress of implementation of clinical pharmacy education in Turkey. The stepwise method has been successfully followed in the implementation of clinical pharmacy education in Turkey. In the undergraduate program, the first step taken was the addition of clinical courses, such as the role of clinical pharmacy, patient education, etc. and practical hospital rounds (internal medicine, pediatrics, and surgery). The post-graduate program, such as master (MSc) and doctoral (Ph.D.) degrees, also offered to prepare clinically oriented pharmacy academicians. The continuous education programs were structured to implement clinical pharmacy idea for the pharmacists in practice. In conclusion, the stepwise approach significantly smoothed the transition from the product-oriented to the patient-oriented pharmacy education. Moreover, the adoption of the skills education system to educate pharmacists needs to review the policy regularly and gradually change it accordingly.Publication Metadata only Serum Lityum Düzeyi Yüksek Olan Hastada Olası İlaçla İlgili Problemler: Bir Olgu Raporu(2021-06-17T00:00:00Z) Özmen, Özge; Sosyal, Damla; Bektay, Muhammed Yunus; Gürsoy, Azize Esra; İzzettin, Fikret Vehbi; ÖZMEN, ÖZGE; SOSYAL, DAMLA; BEKTAY, MUHAMMED YUNUS; GÜRSOY, AZIZE ESRA; İZZETTİN, FIKRET VEHBIPublication Metadata only Treatment of coronavirus disease 2019: a comprehensive review(2020-11-01T00:00:00Z) Sosyal, Damla; Özmen, Özge; Bektay, Muhammed Yunus; İzzettin, Fikret Vehbi; SOSYAL, DAMLA; ÖZMEN, ÖZGE; BEKTAY, MUHAMMED YUNUS; İZZETTİN, FIKRET VEHBIThe new type of Coronavirus (SARS-CoV-2) is a highly contagious pathogen that causes severe acute respiratory syndrome and can be transmitted from human to human. COVID-19, which has been declared as a pandemic by the world health organization and is infected with more than 50 million people, is also responsible for the death of more than 1 million people. There is no sufficient data from randomized clinical trials that any potential treatment improves outcomes in COVID-19 patients. Chloroquine and hydroxychloroquine, antivirals such as favipiravir, lopinavir/ritonavir, immunomodulatory agents tocilizumab, siltuximab, and sarilumab, and anti-inflammatory drugs such as steroids are used for the treatment of COVID-19. Repurposing drugs can provide new treatment options faster than discovering new drugs due to the known safety profiles of existing drugs. On the other hand, there are new drug and vaccine trials for COVID-19. Many researchers, governmental or non-governmental institutions having clinical trials for COVID-19 drugs and vaccines. In this comprehensive review, we investigate the clinical features, management, and treatment of COVID-19 and possible adverse effects and important information related to drugs used for COVID-19. For future preparedness and readiness, new laws and legislations should be constituted. Besides, emergency teams and budgets should be prepared as well.Publication Metadata only Böbrek Yetmezliğinde Alfa-1 Adrenerjik Reseptör Blokör Kullanımı: Bir Olgu Raporu(2021-06-17T00:00:00Z) Bekler, Tubanur; Bektay, Muhammed Yunus; İzzettin, Fikret Vehbi; BEKLER, TUBANUR; BEKTAY, MUHAMMED YUNUS; KARATOPRAK, CUMALİ; İZZETTİN, FIKRET VEHBIPublication Metadata only ECZACILARIN ASTIM FARMASÖTİK BAKIMINDA BİLGİ SEVİYESİ TUTUM VE DAVRANIŞLARININ ARAŞTIRILMASI(2022-05-07T00:00:00Z) Çakmak, Dilan; Bektay, Muhammed Yunus; İzzettin, Fikret Vehbi; BEKTAY, MUHAMMED YUNUS; İZZETTİN, FIKRET VEHBIPublication Metadata only Oncology Pharmacy Practice: The Clinical Pharmacist’s Perspective(2021-07-01T00:00:00Z) Bektay, Muhammed Yunus; İzzettin, Fikret Vehbi; BEKTAY, MUHAMMED YUNUS; İZZETTİN, FIKRET VEHBIIncidence of cancer is increasing all over the world and personalized therapies have become the trend in cancer therapy. Multidisciplinary approaches provide successful results for personalized therapies. As a part of a multidisciplinary healthcare team, oncology pharmacists (OPs) contribute to the rational use of chemotherapy by providing individual pharmaceutical care for cancer patients. A multidisciplinary approach is crucial for the success of cancer therapy. Pharmacists acting as a counsellor for medication-related issues in the multidisciplinary team have a vital role in the oncology setting. OPs are the clinical pharmacists specialized in oncology and they are involved in planning and implementation of pharmaceutical care. Additionally, OPs play an important role in providing comprehensive medication management and related care for cancer patients. We hope that this book will contribute to pharmacists’ knowledge and practice in cancer management by provision of a clinical pharmacist’s perspective.